SARRA VASHCHENKO: Open Payments
NPI 1831199157 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 90 payments from 14 companies in 2025. Trend: 2023 $685 · 2024 $1,475 · 2025 $1,779
Food & beverage: $1,660Education: $119
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $456 |
| ABBVIE INC. | 26 | $287 |
| UCB, Inc. | 10 | $222 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $142 |
| Galderma Laboratories, L.P. | 6 | $128 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| GENZYME CORPORATION | 3 | $111 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Arcutis Biotherapeutics, Inc. | 4 | $69 |
| Amgen Inc. | 2 | $47 |
Products named: TREMFYA, Bimzelx, SKYRIZI, ILUMYA, DUPIXENT, NEMLUVIO, COSENTYX, RINVOQ.
Industry payments across WA — which companies pay providers there.
